Three-year data from a comparative study with recombinant human growth hormone in the treatment of short stature in young children with intrauterine growth retardation-Reference-Cited by-同舟云学术

Three-year data from a comparative study with recombinant human growth hormone in the treatment of short stature in young children with intrauterine growth retardation

Published:2007-01-02 Issue:5 Volume:87 Page:511-517
ISSN:0803-5253
Container-title:Acta Paediatrica
language:en
Short-container-title:

Author:

Fjellestad-Paulsen A,Czernichow P,Brauner R,Bost M,Colle M,Lebouc JY,Lecornu M,Leheup B,Limal JM,Raux MC,Toublanc JE,Rappaport R

Publisher

Wiley

Subject

General Medicine,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1651-2227.1998.tb01495.x/fullpdf

Reference33 articles.

1. Longitudinal follow-up of growth in children born small for gestational age;Albertsson-Wikland;Acta Paediatr,1993

2. Prediction of the outcome of growth at 2 years of age in neonates with intrauterine growth retardation;Léger;Early Hum Dev,1997

3. Follow up study of small-for-date babies;Fancourt;Br Med J,1976

4. Growth of ‘small for date’ babies;Davies;Early Hum Dev,1981

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short stature due to intrauterine growth retardation. Clinical and hormonal-metabolic features, possibilities of growth-stimulating therapy;Problems of Endocrinology;2022-10-23

2. A 2-year multicentre, open-label, randomized, controlled study of growth hormone (Genotropin®) treatment in very young children born small for gestational age: Early Growth and Neurodevelopment (EGN) Study;Clinical Endocrinology;2015-11-25

3. Is the decision on the use of biosimilar growth hormone based on high quality scientific evidence? – a systematic review;European Journal of Clinical Pharmacology;2014-02-26

4. The benefits of growth hormone therapy in patients with Turner syndrome, Noonan syndrome and children born small for gestational age;Growth Hormone & IGF Research;2011-12

5. A Single-Arm, Phase III Study to Assess Efficacy and Safety after 6-Month-Treatment of Eutropin™ Inj. (Recombinant Human Growth Hormone) in Prepubertal Children with Short Stature due to Small for Gestational Age;Journal of Korean Society of Pediatric Endocrinology;2011